Kirby-Bauer disk susceptibility tests with five standard cephalosporin disks were performed on 23 penicillin-resistant Streptococcus pneumoniae isolates for which ceftriaxone MICs were 0.125 to 4 ,ug/ml. Cefuroxime disk inhibition zone diameters distinguished clearly isolates for which ceftriaxone MICs were .2 ,ug/ml from more susceptible strains, whereas cephalothin, ceftizoxime, cefotaxime, and ceftriaxone disks distinguished these isolates less clearly than the cefuroxime disk did.
Patients with pneumococcal meningitis who fail therapy with an extended-spectrum cephalosporin have been reported recently (2, 3, 6) . For the causative strains in these patients, cefotaxime or ceftriaxone MICs were found to be .2 ,ug/ml. Because an extended-spectrum cephalosporin is most frequently used as empiric treatment for childhood meningitis, the early detection of strains with decreased susceptibilities to cephalosporins is vital. We performed Kirby-Bauer disk susceptibility tests with standard cephalosporin disks on 23 penicillin-resistant pneumococcal strains, including 5 strains for which ceftriaxone MICs were .2 ,ug/ml; 4 of the strains were isolated from children with meningitis who failed cefotaxime or ceftriaxone therapy (3, 6) .
Colonies from overnight growth on blood agar plates were suspended in Mueller-Hinton broth, and the turbidity was adjusted to match that of a 0. Fifteen strains were relatively resistant to penicillin (MICs, 0.1 to 1.0 ,ug/ml) and eight strains were highly resistant to penicillin (MICs, .2 ,ug/ml). For 8 strains ceftriaxone MICs were c0.5 ,ug/ml, for 10 strains ceftriaxone MICs were 1 jig/ml, for 1 strain the ceftriaxone MIC was 2 ,ug/ml, and for 4 strains ceftriaxone MICs were 24 ,ug/ml.
Cefotaxime MICs were within one twofold dilution of the ceftriaxone MICs. The ceftriaxone MICs and MBCs for 19 strains were the same, and the MBCs for the other four strains were twofold greater than the corresponding MICs. The distribution of inhibition zone diameters obtained with each of the disks is shown in Fig. 1A to D. Some inhibition zones (with each of the disks) had indistinct borders or had a zone of light growth within a larger inhibition zone. In such instances, the inhibition zone diameters were measured from the innermost ring of colonies. The inhibition zone diameters plotted against cefotaxime MICs were similar to the results obtained with inhibition zone diameters plotted against ceftriaxone MICs (data not shown). The ranges of disk inhibition zone sizes were greater with the cefuroxime, ceftizoxime, and cephalothin disks than with the extended-spectrum cephalosporin disks, and the variation between zone sizes measured on each of three occasions was lowest for the cefuroxime disk. The mean square errors of the three measures were 2.74, 3.33, 4.41, 5.86, and 7.10 for the cefuroxime, ceftriaxone, cefotaxime, ceftizoxime, and cephalothin disks, respectively (one-way analysis of variance for each disk). An inhibition zone diameter cutoff of 20 mm with the cefuroxime disk distinguished strains for which cefotaxime or ceftriaxone MICs were s1 ,.g/ml from those for which MICs were .2 ,ug/ml. The corresponding cutoff for the cefotaxime and ceftriaxone disks was 30 mm, although there was overlap of MICs for strains at this measurement.
Three strains for which ceftriaxone MICs were .4 ,.g/ml had no inhibition zones with the ceftizoxime disk, but two other strains for which ceftriaxone MICs were 4 and 2 ,ug/ml sometimes had zone diameters of .15 mm. With the cephalothin disk, strains for which ceftriaxone MICs were different could not be distinguished. With all disks there was overlap of inhibition zone sizes of strains for which ceftriaxone MICs were 1 ,.g/ml and those for which ceftriaxone MICs were < 1 ,ug/ml, but a ceftizoxime disk diameter of 25 mm separated these strains on all but three occasions. All strains for which the ceftriaxone MIC was .1 ,ug/ml had cefuroxime disk inhibition zone diameters of .30 mm on at least two of the three measurements.
Only a relatively small number of cephalosporin-resistant We recently recommended that initial empiric management of patients with pneumococcal meningitis should include vancomycin and cefotaxime or ceftriaxone (3). We suggest that pneumococcal strains, particularly those isolated from patients with meningitis, should be screened not only with an oxacillin disk but also with a cefuroxime or ceftizoxime disk. Oxacillin-resistant isolates (zone diameter, .19 mm) for which cefuroxime disk inhibition zone diameters are 21 to 30 mm should be regarded as possibly cephalosporin resistant, and those for which inhibition zone diameters are <20 mm should be regarded as definitely resistant pending MIC determinations. The corresponding zone diameters for the ceftizoxime disk (<25 and .18 mm, respectively) would identify resistant strains, but these breakpoints would sometimes include more susceptible strains.
